About Rapid Genomics
Rapid Genomics is a company based in Gainesville (United States) founded in 2011 was acquired by LGC in April 2022. Rapid Genomics has raised $300 thousand across 1 funding round from investors including LGC. Rapid Genomics offers products and services including KASP Genotyping Reagents, Oligos and Primers, PCR Instruments, and NGS Kits. Rapid Genomics operates in a competitive market with competitors including Omniome, Novogene Corporation, Rejuvenate Bio, HitGen and Source BioScience, among others.
- Headquarter Gainesville, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Rapid Genomics Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rapid Genomics
Rapid Genomics offers a comprehensive portfolio of products and services, including KASP Genotyping Reagents, Oligos and Primers, PCR Instruments, and NGS Kits.
Reagents for qPCR-based genotyping in agriculture.
Custom oligonucleotides for DNA and RNA applications.
Devices for high-throughput PCR and genotyping.
Kits for amplicon-based targeted sequencing workflows.
Funding Insights of Rapid Genomics
Rapid Genomics has successfully raised a total of $300K through 1 strategic funding round. The most recent funding activity was a Seed round of $300 thousand completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Rapid Genomics
Rapid Genomics has secured backing from 1 investor. Prominent investors backing the company include LGC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Molecular biology reagents and services are supplied to biotech industries.
|
Locked | Locked | Locked |
Investor details for Rapid Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Rapid Genomics
Investment portfolio details for Rapid Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Rapid Genomics
Detailed financials for Rapid Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Rapid Genomics Comparisons
Peer comparison for Rapid Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Rapid Genomics
Rapid Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Novogene Corporation, Rejuvenate Bio, HitGen and Source BioScience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| Locked | Locked | Locked |
Next-generation gene sequencing and multi-omics technologies are provided.
|
Detailed competitors of Rapid Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Rapid Genomics
Complete news archive for Rapid Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rapid Genomics
Rapid Genomics was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Rapid Genomics is headquartered in Gainesville, United States.
Rapid Genomics is a funded company, having raised a total of $300K across 1 funding round to date.
Rapid Genomics was founded in 2011 in Gainesville, United States, and operates in the genomics sector focused on agriculture. DNA sequencing services are offered to enhance crops and livestock, utilizing capture-sequencing technology for custom targeted applications. Additional services include RNA sequencing, whole genome sequencing, ultraconserved elements analysis, next-generation sequencing, and bioinformatics support. Operations are centered on providing these tools to research and development efforts in the field.
Rapid Genomics's top competitors include Novogene Corporation, Singular Genomics and Source BioScience.
Rapid Genomics offers KASP Genotyping Reagents, Oligos and Primers, PCR Instruments, and NGS Kits.
Rapid Genomics has 1 investor. Key investors include LGC.